I've been thinking again a lot lately about what I call "crisis-dependent functioning" 1 —a pattern I consistently witness in my practice, and among colleagues (and perhaps even personally sometimes) ...

Based on data from the study, a phase 3 confirmatory trial is underway for the humanized monoclonal antibody. Data from a midstage study support the use of nipocalimab in patients not responding to ...